Pharma major Cipla on Tuesday said it is seeking clarity and guidance from the government on the possible roadmap to import vaccine, while stressing that it has been at the forefront of COVID-19 care.
The statement came after a report by PTI on Monday said the company is seeking fast-track approvals to expeditiously bring Moderna’s single-dose COVID-19 booster vaccine into India.
The report quoting sources said Cipla has requested the government for indemnification and exemptions from price capping, bridging trials and basic customs duty, while stating that the firm is close to committing over USD 1 billion as advance to the US major.
In a regulatory filing, the pharma firm said, “Cipla has been at the forefront of COVID care. We are in the process of seeking clarity and guidance from the Government of India for exploring the possible roadmap for vaccine importation to India”.
At this stage, no definitive terms have been finalised and hence, the company cannot comment further, it added.
Shares of Cipla closed at Rs 946.40 per scrip on BSE, down 0.29 per cent from its previous close.
- Over 700 doctors died of Covid-19 during second wave: Indian Medical Association - June 12, 2021
- Puducherry: Health Department to hold ‘vaccination festival’ from June 16 - June 12, 2021
- Covaxin: Bharat Biotech to release 3rd phase efficacy data in 7-8 days - June 12, 2021
- Rajasthan govt announces financial package for children orphaned by Covid - June 12, 2021
- G-7 nations expected to pledge 1 billion vaccine doses for world - June 11, 2021
- Japan city uses tsunami lessons for COVID-19 vaccinations - June 11, 2021
- Over 1.17 crore COVID-19 vaccine doses available with states: Centre - June 11, 2021
- “JCB India announces a COVID Relief Package for its employees, aims to Vaccinate all its employees” - June 11, 2021
- Govt issues guidelines on COVID in children; suggests rational use of CT scan; Remdesivir not recommended - June 10, 2021
- Antibody Cocktail treatment during Covid-19: Here’s everything you need to know about it - June 10, 2021